Literature DB >> 24829508

Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis.

Rushi Gandhi1, James Yi1, Jihyen Ha2, Hang Shi3, Ola Ismail2, Sahra Nathoo2, Joseph V Bonventre4, Xizhong Zhang5, Lakshman Gunaratnam6.   

Abstract

Efficient clearance of apoptotic cells (efferocytosis) prevents inflammation and permits repair following tissue injury. Kidney injury molecule-1 (KIM-1) is a receptor for phosphatidylserine, an "eat-me" signal exposed on the surface of apoptotic cells that marks them for phagocytic clearance. KIM-1 is upregulated on proximal tubule epithelial cells (PTECs) during ischemic acute kidney injury (AKI), enabling efferocytosis by surviving PTECs. KIM-1 is spontaneously cleaved at its ectodomain region to generate a soluble fragment that serves a sensitive and specific biomarker for AKI, but the biological relevance of KIM-1 shedding is unknown. Here, we sought to determine how KIM-1 shedding might regulate efferocytosis. Using cells that endogenously and exogenously express KIM-1, we found that hydrogen peroxide-mediated oxidative injury or PMA treatment accelerated KIM-1 shedding in a dose-dependent manner. KIM-1 shedding was also accelerated when apoptotic cells were added. Accelerated shedding or the presence of excess soluble KIM-1 in the extracellular milieu significantly inhibited efferocytosis. We also identified that TNF-α-converting enzyme (TACE or ADAM17) mediates both the spontaneous and PMA-accelerated shedding of KIM-1. While accelerated shedding inhibited efferocytosis, we found that spontaneous KIM-1 cleavage does not affect the phagocytic efficiency of PTECs. Our results suggest that KIM-1 shedding is accelerated by worsening cellular injury, and excess soluble KIM-1 competitively inhibits efferocytosis. These findings may be important in AKI when there is severe cellular injury.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  efferocytosis; kidney injury molecule-1 (KIM-1); proximal tubule epithelial cells (PTECs); receptor; shedding

Mesh:

Substances:

Year:  2014        PMID: 24829508      PMCID: PMC4380482          DOI: 10.1152/ajprenal.00638.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  89 in total

1.  Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.

Authors:  Konosuke Morimoto; William J Janssen; Michael B Fessler; Kathleen A McPhillips; Valeria M Borges; Russell P Bowler; Yi-Qun Xiao; Jennifer A Kench; Peter M Henson; R William Vandivier
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

Review 2.  Phosphatidylserine recognition by phagocytes: a view to a kill.

Authors:  Yi Wu; Nitu Tibrewal; Raymond B Birge
Journal:  Trends Cell Biol       Date:  2006-03-10       Impact factor: 20.808

3.  H2O2 activates G protein, α 12 to disrupt the junctional complex and enhance ischemia reperfusion injury.

Authors:  Wanfeng Yu; Sarah Beaudry; Hideyuki Negoro; Ilene Boucher; Mei Tran; Tianqing Kong; Bradley M Denker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

4.  Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response.

Authors:  See Heng Wong; Jillian L Barlow; Stephen Nabarro; Padraic G Fallon; Andrew N J McKenzie
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

5.  Protection of renal epithelial cells against oxidative injury by endoplasmic reticulum stress preconditioning is mediated by ERK1/2 activation.

Authors:  Cheng-Chieh Hung; Takaharu Ichimura; James L Stevens; Joseph V Bonventre
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

Review 6.  Apoptotic pathways in ischemic acute renal failure.

Authors:  Gur P Kaushal; Alexei G Basnakian; Sudhir V Shah
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

Review 7.  Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury.

Authors:  W Lieberthal; J S Levine
Journal:  Am J Physiol       Date:  1996-09

8.  Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

Authors:  J Arribas; L Coodly; P Vollmer; T K Kishimoto; S Rose-John; J Massagué
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

9.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

10.  Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.

Authors:  César Santiago; Angela Ballesteros; Cecilia Tami; Laura Martínez-Muñoz; Gerardo G Kaplan; José M Casasnovas
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

View more
  12 in total

1.  Kidney injury molecule-1 protects against Gα12 activation and tissue damage in renal ischemia-reperfusion injury.

Authors:  Ola Z Ismail; Xizhong Zhang; Junjun Wei; Aaron Haig; Bradley M Denker; Rita S Suri; Alp Sener; Lakshman Gunaratnam
Journal:  Am J Pathol       Date:  2015-03-07       Impact factor: 4.307

2.  G protein α12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis.

Authors:  Ola Z Ismail; Xizhong Zhang; Joseph V Bonventre; Lakshman Gunaratnam
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-23

3.  Mapping and functional characterization of murine kidney injury molecule-1 proteolytic cleavage site.

Authors:  Saranga Sriranganathan; Elena Tutunea-Fatan; Alina Abbasi; Lakshman Gunaratnam
Journal:  Mol Cell Biochem       Date:  2020-11-19       Impact factor: 3.396

4.  Extracellular Signal-Regulated Kinase 1/2 Regulates Mouse Kidney Injury Molecule-1 Expression Physiologically and Following Ischemic and Septic Renal Injury.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2017-10-26       Impact factor: 4.030

5.  Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma.

Authors:  Jasper C Lee; Demitra M Yotis; Ji Yun Lee; Marie A Sarabusky; Bradly Shrum; Audrey Champagne; Ola Z Ismail; Elena Tutunea-Fatan; Hon S Leong; Lakshman Gunaratnam
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

Review 6.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

Review 7.  Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart.

Authors:  Matthew DeBerge; Shuang Zhang; Kristofor Glinton; Luba Grigoryeva; Islam Hussein; Esther Vorovich; Karen Ho; Xunrong Luo; Edward B Thorp
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

Review 8.  New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report.

Authors:  Mélanie Dieudé; Lori J West; Daniel A Muruve; Lakshman Gunaratnam; Thalachallour Mohanakumar; Emmanuel Zorn; Christopher W Cairo; Darren H Freed; Kirk R Schultz; Robert L Fairchild; Marie-Josée Hébert
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

9.  KIM-1-mediated anti-inflammatory activity is preserved by MUC1 induction in the proximal tubule during ischemia-reperfusion injury.

Authors:  Mohammad M Al-Bataineh; Carol L Kinlough; Zaichuan Mi; Edwin K Jackson; Stephanie M Mutchler; David R Emlet; John A Kellum; Rebecca P Hughey
Journal:  Am J Physiol Renal Physiol       Date:  2021-06-21

10.  Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

Authors:  Natalia Nowak; Jan Skupien; Monika A Niewczas; Masayuki Yamanouchi; Melissa Major; Stephanie Croall; Adam Smiles; James H Warram; Joseph V Bonventre; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.